纳米颗粒展示猪圆环病毒3型Cap抗原表位的免疫效果评价OA北大核心
Evaluation of Immune Effects of Nanoparticle Displaying Cap Epitopes of Porcine Circovirus Type 3
为了验证纳米颗粒展示圆环病毒3型(PCV3)衣壳蛋白(Cap)串联表位的免疫效果,本试验通过多肽的点杂交和酶联免疫斑点法(ELISPOT)筛选B细胞表位和T细胞表位,通过SpyCatcher/SpyTag(SpyCatcher和SpyTag均为纤维连接蛋白FbaB的结构域,可自发形成异肽键)将表位串联并展示于E2pCD(纳米颗粒展示平台)表面,应用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和透射电子显微镜(TEM)分别检测蛋白的表达情况和颗粒组装情况,通过酶联免疫吸附试验(ELISA)和流式细胞术分别检测纳米颗粒展示PCV3 Cap抗原表位免疫后猪血清PCV3抗体水平和外周血T淋巴细胞增殖水平.结果显示,共筛选出 3 个 B 细胞表位[P10:73~87aa(ETAISFEYYKILKMK)、P21:161~175aa(QSLFFFSRPTPWLNT)、P26:201~214aa(YGTKEVWIRYKSVL)]和 3 个 T 细胞表位[P20:153~167aa(GTTSAHPGQSLFFFS)、P21:161~175aa(QS-LFFFSRPTPWLNT)、P24:185~199aa(LLWSIYVPEKTGMTD)].SDS-PAGE 检测结果显示,SpyCatcher-E2pCD、PCV3 Cap(P10-P20~P26)-SpyTag 和 SpyCatcher-E2pCD-PCV3 Cap(P10-P20~P26)-SpyTag 分子量分别为 40、16 和 55kDa.通过 TEM可以检测到 SpyCatcher-E2pCD 和 SpyCatcher-E2pCD-PCV3 Cap(P10-P20~P26)-SpyTag 均形成直径约 22 nm 的纳米颗粒.免疫效果评价结果显示,免疫后21 d时,SpyCatcher-E2pCD-PCV3 Cap(P10-P20~P26)-SpyTag免疫猪产生的特异性抗体水平以及CD4+、CD8+和CD4+CD8+淋巴细胞比例均极显著高于PCV3 Cap(P10-P20~P26)-SpyTag(P<0.001).结果表明,通过SpyCatcher-E2pCD展示PCV3 Cap串联表位具有较好的免疫效果,可以为PCV3候选疫苗的研制提供借鉴.
To verify the immune effects of nanoparticle displaying epitopes from the capsid protein(Cap)of porcine circovirus type 3(PCV3),this study screened B-cell and T-cell epitopes using peptide spot hybridization and enzyme-linked immunospot assay(ELISPOT).Epitopes were linked and displayed on the surface of E2pCD(nanoparticle display platform)using SpyCatcher/SpyTag(domains of the fibronectin-binding protein FbaB capable of forming spontaneous isopeptide bonds).Protein expression and particle assembly were detected using sodium dodecyl sulfate-polyacrylamide gel electrophoresis(SDS-PAGE)and transmission electron microscopy(TEM),respectively.Enzyme-linked immunosorbent assay(ELISA)and flow cytometry were employed to evaluate the levels of PCV3 Cap antigen-specific antibodies in pig sera and peripheral blood T lymphocyte proliferation levels after immunization.The study identified 3 B-cell epitopes[P10:73-87aa(ETAISFEYYKILKMK),P21:161-175aa(QSLFFFSRPTPWLNT),P26:201-214aa(YGTKEVWIRYKSVL)]and 3 T-cell epitopes[P20:153-167aa(GTTSAHPGQSLFFFS),P21:161-175aa(QSLFFFSRPTPWLNT),P24:185-199aa(LLWSIYVPEKTGMTD)].SDS-PAGE results showed molecular weights of 40 kDa for SpyCatcher-E2pCD,16 kDa for PCV3 Cap(P10-P20~P26)-SpyTag,and 55 kDa for SpyCatcher-E2pCD-PCV3 Cap(P10-P20~P26)-SpyTag.TEM revealed the formation of nanoparticles with a diameter of approximately 22 nm for SpyCatcher-E2pCD and SpyCatcher-E2pCD-PCV3 Cap(P10-P20~P26)-SpyTag.Evaluation of immune effects demonstrated that 21 days post-immunization,specific antibody levels and proportions of CD4+,CD8+,and CD4+CD8+lymphocytes were significantly higher in pigs immunized with SpyCatcher-E2pCD-PCV3 Cap(P10-P20~P26)-SpyTag compared to PCV3 Cap(P10-P20~P26)-SpyTag(P<0.001).These results indicate that SpyCatcher-E2pCD displaying PCV3 Cap concatenated epitopes exhibits promising immune effects,providing insights for the development of PCV3 candidate vaccines.
李欢欢;田克恭;梁严予;岳亚男;刘亚婷;白小飞;陈赵媛;王彦伟;黄玉欣;逄文强
国家兽用药品工程技术研究中心,河南洛阳 471000||普莱柯生物工程股份有限公司,河南洛阳 471000
畜牧业
猪圆环病毒3型(PCV3)表位筛选纳米颗粒
porcine circovirus type 3(PCV3)epitope screeningnanoparticle
《中国兽医杂志》 2024 (007)
1-8 / 8
郑洛新国家自主创新示范区创新引领型产业集群专项(201200211200)
评论